InvestSMART

Bubs Australia Limited (ASX: BUB) - Announcements

Current share price for BUB : $0.079 0.003 (3.66%)+

ASX company news and announcements for Bubs Australia Limited (BUB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bubs Australia Limited (BUB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bubs Australia Limited (BUB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bubs Australia Limited (BUB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$71 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2026 8:21AM $0.089 $0.079 fallen by 11.24%
$71 Response to ASX 3Y Query 23 Oct 2026 12:01PM $0.091 $0.079 fallen by 13.19%
$71 Change of Director's Interest Notice - JC 20 Oct 2026 1:11PM $0.095 $0.079 fallen by 16.84%
$71 Annual General Meeting - Notice of Access 16 Oct 2026 9:19AM $0.095 $0.079 fallen by 16.84%
$71 Notice of Annual General Meeting/Proxy Form 16 Oct 2026 9:18AM $0.095 $0.079 fallen by 16.84%
$71 Notification regarding unquoted securities - BUB 14 Oct 2026 12:49PM $0.098 $0.079 fallen by 19.39%
$71 Annual Report 14 Oct 2026 8:42AM $0.096 $0.079 fallen by 17.71%
$71 Cleansing Notice 13 Oct 2026 12:47PM $0.096 $0.079 fallen by 17.71%
$71 Application for quotation of securities - BUB 13 Oct 2026 10:01AM $0.099 $0.079 fallen by 20.20%
$71 Change of Director's Interest Notice - PJ 17 Sep 2026 8:23AM $0.110 $0.079 fallen by 28.18%
$71 Date of AGM and Closing Date for Director Nominations 14 Sep 2026 4:01PM $0.115 $0.079 fallen by 31.30%
$71 Change of Director's Interest Notice - LTM 14 Sep 2026 8:22AM $0.115 $0.079 fallen by 31.30%
$71 Response to ASX Aware Query 10 Sep 2026 1:51PM $0.125 $0.079 fallen by 36.80%
$71 FDA Approval Webinar Presentation 10 Sep 2026 9:39AM $0.130 $0.079 fallen by 39.23%
$71 FDA Approval Webinar Notification 8 Sep 2026 2:08PM $0.135 $0.079 fallen by 41.48%
$71 Bubs Secures Permanent US FDA Approval for Infant Formula 7 Sep 2026 9:08AM $0.100 $0.079 fallen by 21%
$71 Trading Halt 4 Sep 2026 1:30PM $0.100 $0.079 fallen by 21%
$71 Pause in Trading 4 Sep 2026 12:54PM $0.100 $0.079 fallen by 21%
$71 Change of Director's Interest Notice - LTM 4 Sep 2026 10:57AM $0.097 $0.079 fallen by 18.56%
$71 Change of Director's Interest Notice - PDP 3 Sep 2026 1:23PM $0.086 $0.079 fallen by 8.14%
$71 Change of Director's Interest Notice - PJ 3 Sep 2026 9:25AM $0.088 $0.079 fallen by 10.23%
$71 FY26 Appendix 4G and Corporate Governance Statement 27 Aug 2026 8:09AM $0.093 $0.079 fallen by 15.05%
$71 FY26 Results Presentation 27 Aug 2026 8:08AM $0.093 $0.079 fallen by 15.05%
$71 FY26 Results 27 Aug 2026 8:06AM $0.093 $0.079 fallen by 15.05%
$71 FY26 Appendix 4E and Preliminary Annual Report 27 Aug 2026 8:06AM $0.093 $0.079 fallen by 15.05%

1 - 25 of 552 results

Page 1 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.